Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
ClinicalTrials.gov ID: NCT06721455
For more information on this trial, visit clinicaltrials.gov
This study aims to learn more about blood management in children undergoing heart surgery, such as the right amounts, and the best blood products, to administer. It also aims to develop a mathematical model that may help researchers better predict and treat patients who need blood transfusions during heart surgery.
NOT_YET_RECRUITING
Inclusion Criteria:
* pediatric patients under 18 years of age undergoing cardiac surgery with clear prime on cardio-pulmonary bypass (CPB) at Boston Children's Hospital (BCH).
Exclusion Criteria:
* patients with known hemolytic disorders, patients on nitric oxide preoperatively, and patients found to have abnormal coagulation on routine preoperative assessment. Patients receiving heparin, American Society of Anesthesia (ASA) status, apixaban, warfarin, or bivalirudin held appropriately (i.e. for elective surgery) will not be excluded
ALL
0 Years
17 Years
2025-12-16
This field has been modified from ClinicalTrials.gov to show a contact specific to Boston Children's.
This field has been modified from ClinicalTrials.gov to show a contact specific to Boston Children's.
OTHER
blood sampling
For more information and to contact the study team: